BioCryst Pharmaceuticals (BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs....

|About: BioCryst Pharmaceutical... (BCRX)|By:, SA News Editor
BioCryst Pharmaceuticals (BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs. $23.6M. (PR)